Endometriosis Diagnosis
Endometriosis Diagnosis
There is no blood test that diagnoses this condition, and the scan that people expect to settle it cannot see its commonest form. The diagnosis is made from a history taken by pattern, an examination, and imaging read for what it can and cannot show. Laparoscopy remains the reference standard, because it is the only way to look directly at the peritoneal surface, but it is no longer required before treatment begins. The distinction that matters is between establishing whether the disease is present and deciding what to do next — and only the second one has to be answered immediately.
There is no blood test, and no marker to follow
The absence of a simple test is the reason the diagnosis takes so long, not a sign that the assessment is vague:
- No blood test identifies the disease. There is no marker that rises with it and falls when it is treated, which means the diagnosis rests on the clinical picture rather than on a number.
- CA-125 is not a diagnostic test. It can be raised in this condition and it is raised by many other things, so it is not used to confirm or exclude it. Treating a modestly raised result as evidence of the disease, or of something worse, is a common and avoidable error.
- The history is the primary investigation. When in the cycle the pain occurs, what it comes with, and how it has changed over time carry more diagnostic weight than any single examination or image.
- A long delay is the norm rather than a failure. The interval between the first symptoms and the diagnosis is commonly measured in years, because the symptoms are usual enough to be attributed to normal periods and the commonest form is invisible on imaging.
Why this shapes the whole pathway. A condition diagnosed from a pattern rather than from a test has to be treated on the pattern. Waiting for a result that does not exist is how the delay becomes indefinite.
What ultrasound and MRI can show
Imaging is genuinely useful, and it is worth being precise about what each technique contributes:
- Transvaginal ultrasound is the first-line test. It identifies an ovarian endometrioma reliably, and in experienced hands it identifies many deep lesions involving the tissue behind the cervix, the bowel and the bladder.
- It also shows what else might be going on. Ovaries, the uterus, the lining of the womb and free fluid are all assessed at the same time, which is how conditions that imitate the pain are identified or excluded.
- MRI maps deep disease before surgery. Where the bowel, the bladder or the ureter may be involved, MRI shows the relationships between the disease and those structures, which is what determines who needs to be in the operating theatre.
- Both techniques depend on who is performing and reading them. A scan performed by someone looking specifically for deep disease, with the possibility in mind, finds things a routine scan does not. This is why the request matters as much as the result.
Why imaging is used to plan rather than to decide. What these tests contribute is a map and a set of exclusions. They change what is planned; they do not on their own establish that the disease is absent.
What imaging misses, and why a normal scan means very little
This is the single most important thing to understand about the tests, and the most common reason a diagnosis is delayed:
- The commonest form of the disease is invisible on any scan. Superficial implants on the peritoneum that lines the pelvis are beyond the resolution of ultrasound and MRI alike. A normal scan is therefore the expected result in a large proportion of women who have the disease.
- Adhesions are not seen directly. They are inferred from what has become fixed or displaced. A pelvis that looks normal on imaging can be extensively tethered, and the examination often feels this before an image shows it.
- A negative result is an absence of evidence, not evidence of absence. This sounds like a technicality and it is not: it is the difference between investigating further and closing the question.
- Waiting for a positive scan is how the delay happens. Where each normal scan is taken as reassurance and the pain continues, years can pass with repeated imaging and no progress.
Why this is stated plainly at the first appointment. A woman who has been told her scan was normal and has understood that as an explanation will not come back. Explaining that the scan was never able to answer the question is what keeps the assessment moving.
When laparoscopy is the right next step
Laparoscopy remains the reference standard, and the point is to use it when it will change something:
- To see the peritoneal surface directly. It is the only way to confirm or exclude superficial disease, and it allows the diagnosis to be made with certainty where certainty is needed.
- To treat at the same time as diagnosing. Lesions can be excised or ablated and adhesions divided during the same procedure, which is why an operation planned for diagnosis is usually planned for treatment as well.
- Where the picture is atypical. Pain that does not fit, imaging that suggests something else, or symptoms that have progressed unexpectedly are all reasons to look rather than to keep treating empirically.
- Where first-line treatment has not worked. If medical treatment for the pain has been given an adequate trial and the symptoms persist, laparoscopy provides both an explanation and an opportunity to treat.
Why it is not a routine step. An operation has its own risks, its own recovery and, near an ovary, its own cost. Requiring one before any treatment can begin is what turns a manageable condition into a delayed one, which is why the decision is tied to what it will change.
Treating before the diagnosis is confirmed
This is the part of the pathway most often misunderstood, and it is deliberate:
- Pain can be treated on the clinical picture. Where the history is typical and other causes have been considered, treatment for pain can begin while the diagnosis is described as clinical rather than as confirmed.
- Waiting is a decision with a cost. Pain that is not treated affects work, sleep and mood, and disease that is not treated can progress. Postponing treatment until a laparoscopy is arranged is not a neutral position.
- Treatment also tests the diagnosis. How the pain responds to a hormonal method or to a defined course of treatment is information, and it often changes what is suspected next.
- What the assessment must still do is exclude. Starting treatment on the clinical picture is not the same as never looking for alternatives. The conditions that imitate the pain are assessed in parallel, not afterwards.
Why this is stated explicitly in the plan. Many women arrive expecting to be told nothing can be done until an operation has confirmed the diagnosis. Correcting that expectation is part of the consultation, because the alternative is another year of untreated pain.
What is not done, and why
A useful assessment is defined as much by what it leaves out as by what it includes:
- Repeated ultrasound to watch the disease is not useful. Imaging does not track the activity of peritoneal disease, so repeating it at intervals produces reassurance that is not supported by what the test can show.
- Serial blood markers are not part of follow-up. There is no marker to follow, and treating a non-specific result as a measure of disease activity leads to decisions that are not based on anything.
- Laparoscopy is not repeated to confirm what is already established. A further operation carries its own cost, and repeating it to look rather than to treat is a decision that needs a specific reason.
Why saying no is part of the plan. A woman who has had pelvic pain for years will accept almost any test that is offered, and a test that cannot answer the question only postpones the treatment that can. Naming what will not be done is how the assessment stays about decisions.